Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Cyxone

Less than 1K followers
All
Research
Press releases
ShowingAll content types
Regulatory press release8/26/2024, 12:19 PM

Cyxone AB announces last day of trading in BTA

Cyxone
Regulatory press release8/16/2024, 6:59 AM

Cyxone AB publishes outcome of rights issue

Cyxone
Regulatory press release8/1/2024, 6:45 AM

The subscription period in Cyxone's rights issue starts today

Cyxone

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release7/31/2024, 6:45 AM

Cyxone AB publishes investment memorandum

Cyxone
Regulatory press release7/23/2024, 6:30 AM

Cyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

Cyxone
Press release7/15/2024, 6:42 AM

Cyxone provides an update on its research and development program

Cyxone
Regulatory press release4/22/2024, 8:02 AM

Kjell Stenberg new CEO in Cyxone AB

Cyxone
Press release3/28/2024, 10:52 AM

BioStock: Cyxone comments on the clinical collaboration in the UK

Cyxone
Press release3/25/2024, 12:44 PM

Cyxone enters important research collaboration

Cyxone
Press release3/5/2024, 8:42 AM

BioStock: Cyxone's CEO gives a status update

Cyxone
Press release1/17/2024, 7:45 AM

BioStock: Cyxone identifies target protein for rabeximod

Cyxone
Press release1/15/2024, 9:01 AM

Cyxone reaches important milestone regarding mechanism of action

Cyxone
Press release11/20/2023, 8:22 AM

Cyxone welcomes a renewed engagement by Professor Rikard Holmdahl as Scientific Advisor

Cyxone
Regulatory press release10/27/2023, 6:29 AM

Cyxone: Interim Report 1 January to 30 September 2023

Cyxone
Regulatory press release10/9/2023, 6:38 AM

Cyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K

Cyxone
Press release9/27/2023, 7:30 AM

BioStock Investor Meeting: Cyxone

Cyxone
Regulatory press release8/30/2023, 6:32 AM

Cyxone: Interim Report 1 January to 30 June 2023

Cyxone
Regulatory press release8/29/2023, 5:03 PM

Cyxone revises strategy for commercial alignment targeting valuable market opportunities

Cyxone
Regulatory press release6/15/2023, 6:30 AM

Cyxone appoints Urban Ottosson as new CFO

Cyxone
Press release5/31/2023, 12:00 PM

Cyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K

Cyxone
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.